Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-2-17
pubmed:abstractText
There have been only a few studies concerning oral prednisolone and mizoribine therapy for diffuse IgA nephritis (IgAN). We evaluated the efficacy of prednisolone and mizoribine therapy for diffuse IgAN.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0250-8095
pubmed:author
pubmed:copyrightInfo
Copyright 2004 S. Karger AG, Basel
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
147-53
pubmed:dateRevised
2007-2-14
pubmed:meshHeading
pubmed-meshheading:14726626-Anticoagulants, pubmed-meshheading:14726626-Biopsy, pubmed-meshheading:14726626-Child, pubmed-meshheading:14726626-Dilazep, pubmed-meshheading:14726626-Disease Progression, pubmed-meshheading:14726626-Female, pubmed-meshheading:14726626-Follow-Up Studies, pubmed-meshheading:14726626-Glomerulonephritis, IGA, pubmed-meshheading:14726626-Humans, pubmed-meshheading:14726626-Immunosuppressive Agents, pubmed-meshheading:14726626-Kidney Glomerulus, pubmed-meshheading:14726626-Male, pubmed-meshheading:14726626-Prednisolone, pubmed-meshheading:14726626-Prospective Studies, pubmed-meshheading:14726626-Ribonucleosides, pubmed-meshheading:14726626-Severity of Illness Index, pubmed-meshheading:14726626-Treatment Outcome, pubmed-meshheading:14726626-Vasodilator Agents, pubmed-meshheading:14726626-Warfarin
pubmed:articleTitle
Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy.
pubmed:affiliation
Department of Pediatrics, Fukushima Medical University School of Medicine, Fukushima City, Fukushima, Japan. tomo@fmu.ac.jp
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study